semaglutide ema approval Novo Nordisk Submits 7.2 mg Wegovy to for Obesity Treatment | Paramesh Shamanna posted on the topic Novo Nordisk secures FDA approval

Vitamin B12, supports red blood cell formation in the body

A small clinical study concluded that dulaglutide did not activate the HPA axis, however measurements were limited to cortisol measurements after dexamethasone suppression and ACTH stimulation

Key takeaways Ozempic is an FDA-approved injectable medication for improving blood sugar in adults with Type 2 diabetes and reducing cardiovascular risk

Among those familiar with these drugs, 53% think they are good options to lose weight for people with obesity or a weight-related health condition, while just 19% think they are not good options and 28% say theyre not sure

doi: 10.2337/dc15-1025 Summary Keywords obesity, adiposity, insulin resistance, overweight, weight loss Citation Resnick O, Bril F and Beauchamp G (2025) Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer

Antioxidante natural